{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:28Z","timestamp":1791820948320,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270053"],"award-info":[{"award-number":["81270053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573810"],"award-info":[{"award-number":["81573810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["16ZR1437800"],"award-info":[{"award-number":["16ZR1437800"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.clinre.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T01:33:56Z","timestamp":1552095236000},"page":"575-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway"],"prefix":"10.1016","volume":"43","author":[{"given":"Yang","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.clinre.2019.02.003_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2019.02.003_bib0025","first-page":"2201","article-title":"Functional analysis of differential microRNA expression profile in mouse fibrotic liver tissues induced by CCl4","volume":"29","author":"Wang","year":"2013","journal-title":"Chin J Pathophysiol"},{"key":"10.1016\/j.clinre.2019.02.003_bib0030","first-page":"310","article-title":"Expresion of miRNA-21\/101\/125a\/195\/200bin hepatic cirrhosis and carcinoma","volume":"22","author":"Lei","year":"2017","journal-title":"Chinese Hepatology"},{"key":"10.1016\/j.clinre.2019.02.003_bib0035","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.2147\/OTT.S141652","article-title":"The prognostic value of decreased mir-101 in various cancers: a meta-analysis of 12 studies","volume":"10","author":"Hu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clinre.2019.02.003_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/CBM-170620","article-title":"MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K\/Akt\/mTOR","volume":"21","author":"Zhang","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.clinre.2019.02.003_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.4373","article-title":"MicroRNA\u2010101 suppresses liver fibrosis by targeting the TGF-\u03b2 signalling pathway","volume":"234","author":"Tu","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.clinre.2019.02.003_bib0050","doi-asserted-by":"crossref","first-page":"16420","DOI":"10.1074\/jbc.M117.805747","article-title":"MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation","volume":"292","author":"Huang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2019.02.003_bib0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinre.2019.02.003_bib0060","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/dneu.20506","article-title":"PI3K\/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation","volume":"67","author":"Peltier","year":"2007","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.clinre.2019.02.003_bib0065","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ijc.25134","article-title":"MMP\u20102 alters VEGF expression via \u03b1V\u03b23 integrin\u2010mediated PI3K\/AKT signaling in A549 lung cancer cells","volume":"127","author":"Chetty","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinre.2019.02.003_bib0070","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.18632\/oncotarget.3279","article-title":"FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia","volume":"6","author":"Nogami","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinre.2019.02.003_bib0075","first-page":"81","article-title":"Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K\/AKT\/mTOR\/p70S6K1 signaling pathways","volume":"23","author":"Peng","year":"2017","journal-title":"Discov Med"},{"key":"10.1016\/j.clinre.2019.02.003_bib0080","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s10620-015-3751-4","article-title":"Wogonoside shows antifibrotic effects in an experimental regression model of hepatic fibrosis","volume":"60","author":"Wang","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2019.02.003_bib0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.biopha.2017.07.005","article-title":"MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K\/AKT signal pathway by targeting MALAT-1","volume":"93","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinre.2019.02.003_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22589","article-title":"Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition","volume":"49","author":"Sohail","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.02.003_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/537234","article-title":"Ergosterol is the Active Compound of Cultured Mycelium Cordyceps sinensis on Antiliver Fibrosis","author":"Peng","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.clinre.2019.02.003_bib0100","first-page":"71","article-title":"Effects of salvianolic acid B on lipid peroxidation and metalloproteinase-2 activity in fibrotic liver in rat","volume":"35","author":"Wang","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.clinre.2019.02.003_bib0105","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2019.02.003_bib0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/jpet.116.234179","article-title":"Swertiamarin attenuates experimental rat hepatic fibrosis by suppressing angiotensin ii-angiotensin type 1 receptor-extracellular signal-regulated kinase signaling","volume":"359","author":"Li","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinre.2019.02.003_bib0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor \u03b2 Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2019.02.003_bib0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.canep.2012.05.004","article-title":"miRNA-101: a potential target for tumor therapy","volume":"36","author":"Gui","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clinre.2019.02.003_bib0125","doi-asserted-by":"crossref","first-page":"e2566","DOI":"10.1038\/cddis.2016.486","article-title":"MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma","volume":"8","author":"Tang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clinre.2019.02.003_bib0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-08-2886","article-title":"MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity","volume":"69","author":"Su","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2019.02.003_bib0135","doi-asserted-by":"crossref","first-page":"e0180173","DOI":"10.1371\/journal.pone.0180173","article-title":"Prognostic significance of microRNA-101 in solid tumor: A meta-analysis","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2019.02.003_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2017.03.171","article-title":"miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines","volume":"487","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinre.2019.02.003_bib0145","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World\u2010wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.02.003_bib0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: role in breast cancer progression, drug resistance, and treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.clinre.2019.02.003_bib0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","article-title":"Emerging role of mTOR in the response to cancer therapeutics","volume":"2","author":"Ilagan","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clinre.2019.02.003_bib0160","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1038\/ncomms5407","article-title":"Rab8a interacts directly with PI3K\u03b3 to modulate TLR4-driven PI3K and mTOR signalling","volume":"5","author":"Luo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinre.2019.02.003_bib0165","doi-asserted-by":"crossref","first-page":"66154","DOI":"10.18632\/oncotarget.19825","article-title":"EDG2 enhanced the progression of hepatocellular carcinoma by LPA\/PI3K\/AKT\/mTOR signaling","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinre.2019.02.003_bib0170","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2019.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/s41418-018-0065-z","article-title":"Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma","volume":"25","author":"Li","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clinre.2019.02.003_bib0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.10.001","article-title":"ERK activation globally downregulates miRNAs through phosphorylating exportin-5","volume":"30","author":"Sun","year":"2016","journal-title":"Cancer Cell"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:28:15Z","timestamp":1761895695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2210740119300415"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.02.003","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}